WebSep 17, 2012 · Jennerex, Inc. is a clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic immunotherapy products for cancer. The Company's lead product JX-594 is currently in … WebIovance Biotherapeutics Study Team Telephone: 866-565-4410 Email: [email protected]: Study Officials: Iovance Biotherapeutics Study Team Study Director Iovance Biotherapeutics : Locations: United States, California: City of Hope …
Jennerex Granted FDA Orphan Drug Designation for Pexa-Vec in ...
WebJennerex, Inc. (San Francisco, USA) was established. 2014. SillaJen acquires Jennerex, Inc. 2015. In April 2015. SillaJen began a Phase 3 clinical trial of Pexa-Vec in advanced liver cancer. 2015. In October 2015, SillaJen is selected as the major developer for the … WebJennerex Biotherapeutics, Inc. develops and commercializes oncolytic immunotherapies for solid tumors. The Company offers products are designed to attack cancer tumors through synergistic and ... honda dirt bikes 250cc for sale
Jennerex Biotherapeutics Raises $21.6M for Cancer Therapy
WebJennerex is a clinical-stage biopharmaceutical company developing targeted oncolytic products for the treatment of cancer. Acquired by SillaJen San Francisco, California, United States 11-50 Private Equity Private www.jennerex.com 87,452 Highlights Total Funding … WebNov 26, 2013 · Jennerex is a clinical-stage biotechnology company focused on the development and commercialization of groundbreaking oncolytic immunotherapies for patients with life-threatening cancers. Jennerex Biotherapeutics, Inc. (now owned by SillaJen) was an American private biopharmaceutical company that developed the oncolytic viruses JX-594 and JX-929 among others. By creating oncolytic viruses that can (1) kill tumor cells directly through lysis, (2) activate the immune system by delivering genes … See more Jennerex received its name in honor of Edward Jenner, the pioneer of the smallpox vaccine and "the father of immunology". Locations Headquarters are located in the Financial District, San Francisco See more 2003. Jennerex, Inc. (San Francisco, USA) was established. 2007. Jennerex completed Pexa-Vec Phase 1 clinical trial (HEP001). 2008. Jennerex … See more Jennerex has partnered with Transgene, Green Cross, Lee's Pharmaceuticals, Rex Medical, and SillaJen for JX-594 development and commercialization. As of October 9, 2012, … See more Oncolytic viruses developed by Jennerex are based on the vaccinia virus. Pexa-Vec (Jx-594) Pexa-Vec is an … See more • JX-594 See more • Jennerex homepage See more honda dirt bike racing shirt